Skip to content

News

10th April 2025

Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer

26th March 2025

International Wound Journal Publishes Positive Phase 2 Interim Data on Cell-free Amniotic Fluid Injectable Biologic for the Treatment of Venous Leg Ulcers

4th March 2025

2025 CAMPS Summit Selects Merakris Therapeutics’ Scientist with Inaugural “Best Comparative Trial” Award

10th December 2024

Merakris Therapeutics Announces Open Enrollment for Phase II Clinical Trial of Subcutaneous Injection Drug for the Treatment of VLU

1st October 2024

Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft

Top